Tubeimoside I induces accumulation of impaired autophagolysosome against cervical cancer cells by both initiating autophagy and inhibiting lysosomal function

Cervical cancer is one of the most aggressive human cancers with poor prognosis due to constant chemoresistance and repeated relapse. Tubeimoside I (TBM) has been identified as a potent antitumor agent that inhibits cancer cell proliferation by triggering apoptosis and inducing cell cycle arrest. Ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Xuping, Zhou, Jing, Li, Jingyi, Hou, Xueyan, Li, Longhao, Chen, Yongmin, Fu, Shuyue, Zhou, Li, Li, Changlong, Lei, Yunlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214972/
https://www.ncbi.nlm.nih.gov/pubmed/30389907
http://dx.doi.org/10.1038/s41419-018-1151-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214972/
https://www.ncbi.nlm.nih.gov/pubmed/30389907
http://dx.doi.org/10.1038/s41419-018-1151-3

Ejemplares similares